Tumor associated antigen specific T cell therapy(Children'S National Research Institute)

肿瘤相关抗原特异性T细胞疗法（Children'S National Research Institute）

Report date: 2022/12/30 15:00:37

Base Information

Drug NameTumor associated antigen specific T cell therapy(Children'S National Research Institute)
Drug Alias NameTAA-T
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesChildren'S National Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesChildren'S National Research Institute
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A